Search hospitals > California > Los Angeles
University of California, Los Angeles
Claim this profileLos Angeles, California 90095
Global Leader in Cancer
Global Leader in Tumors
Conducts research for Melanoma
Conducts research for Lymphoma
Conducts research for Breast Cancer
1327 reported clinical trials
144 medical researchers
Summary
University of California, Los Angeles is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Tumors, Melanoma, Lymphoma, Breast Cancer and other specialties. University of California, Los Angeles is involved with conducting 1,327 clinical trials across 1,232 conditions. There are 144 research doctors associated with this hospital, such as Jacqueline N. Casillas, Zev A. Wainberg, Gary Schiller, MD, and Theodore Moore, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
2Tumors
Global LeaderStage IV
Stage III
FGFR3 positive
Top PIs
Jacqueline N. CasillasMiller Children's and Women's Hospital Long Beach7 years of reported clinical research
Expert in Tumors
Expert in Cancer
46 reported clinical trials
94 drugs studied
Zev A. WainbergUCLA2 years of reported clinical research
Expert in Solid Tumors
Studies Pancreatic Cancer
32 reported clinical trials
64 drugs studied
Gary Schiller, MDUCLA Medical Center6 years of reported clinical research
Expert in Acute Myeloid Leukemia
Expert in Leukemia
30 reported clinical trials
52 drugs studied
Theodore Moore, MDMattel Children's Hospital UCLA7 years of reported clinical research
Studies Tumors
Studies Cancer
21 reported clinical trials
59 drugs studied
Clinical Trials running at University of California, Los Angeles
Cutaneous Melanoma
Prostate Cancer
Breast Cancer
Non-Hodgkin's Lymphoma
Parkinson's Disease
Acute Myeloid Leukemia
Psychosis
Bladder Cancer
Lymphoma
Glioblastoma
Binimetinib + Nivolumab
for Skin Cancer
This phase II trial studies how well binimetinib and nivolumab work in treating patients with BRAF V600 wildtype melanoma that has spread to nearby tissues or lymph nodes and cannot be removed by surgery (locally advanced unresectable) or has spread to other places in the body (metastatic). Binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving binimetinib and nivolumab together may work better in treating patients with melanoma compared to nivolumab alone.
Recruiting1 award Phase 220 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of California, Los Angeles?
University of California, Los Angeles is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Tumors, Melanoma, Lymphoma, Breast Cancer and other specialties. University of California, Los Angeles is involved with conducting 1,327 clinical trials across 1,232 conditions. There are 144 research doctors associated with this hospital, such as Jacqueline N. Casillas, Zev A. Wainberg, Gary Schiller, MD, and Theodore Moore, MD.
Where is University of California, Los Angeles located?
**Directions to UCLA Hospital, Los Angeles:**
- Take the San Diego Freeway (405) to Wilshire Boulevard East.
- Turn left on Westwood Blvd and continue past Le Conte Avenue.
- The hospital is located on the left, past UCLA Medical Plaza.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at UCLA Hospital, contact the Patient Business Services Office at 310-825-8021, available Monday through Friday, 8:30 am to 4:00 pm. They offer support with the Financial Assistance Program, including eligibility, application process, and discounts for qualifying patients. Assistance with insurance coverage and billing questions is also available.
What insurance does University of California, Los Angeles accept?
The University of California, Los Angeles (UCLA) accepts a variety of insurance plans, including:
1. **UC-sponsored medical plans**: Designed to meet the health care and insurance needs of UCLA employees and their families.
2. **Blue Shield Exclusive PPO Network**: Available through Covered California for 2023.
3. **Cigna + Oscar - Open Access Plus**: For small businesses, accessible through Covered California.
4. **L.A. Care Health Plan Covered California**: Offered through Covered California.
5. **UC Care**: A PPO plan for UC employees and retirees not enrolled in Medicare, managed by Anthem Blue Cross (medical) and Navitus (pharmacy).
6. **UC Student Health Insurance Plan (UC SHIP)**: A systemwide plan providing enhanced health benefits to all enrolled students.
Please verify with the specific department or service at UCLA to confirm the acceptance of your insurance plan.
What awards or recognition has University of California, Los Angeles received?
The University of California, Los Angeles (UCLA) hospital is ranked third on the national honor roll and has been recognized as one of America's Best Hospitals for 21 consecutive years. It boasts top 10 national rankings in 12 specialties, including cancer, neurology and neurosurgery, orthopedics, and pulmonology and lung surgery. The David Geffen School of Medicine at UCLA received $303 million in funding from the National Institutes of Health for 2023-24, highlighting its significant research efforts.